全文获取类型
收费全文 | 7123篇 |
免费 | 333篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 146篇 |
妇产科学 | 246篇 |
基础医学 | 1099篇 |
口腔科学 | 123篇 |
临床医学 | 552篇 |
内科学 | 1454篇 |
皮肤病学 | 161篇 |
神经病学 | 843篇 |
特种医学 | 403篇 |
外国民族医学 | 1篇 |
外科学 | 778篇 |
综合类 | 73篇 |
一般理论 | 1篇 |
预防医学 | 535篇 |
眼科学 | 57篇 |
药学 | 581篇 |
中国医学 | 15篇 |
肿瘤学 | 366篇 |
出版年
2021年 | 101篇 |
2020年 | 52篇 |
2019年 | 92篇 |
2018年 | 100篇 |
2017年 | 91篇 |
2016年 | 111篇 |
2015年 | 137篇 |
2014年 | 179篇 |
2013年 | 225篇 |
2012年 | 336篇 |
2011年 | 328篇 |
2010年 | 209篇 |
2009年 | 206篇 |
2008年 | 284篇 |
2007年 | 298篇 |
2006年 | 282篇 |
2005年 | 309篇 |
2004年 | 259篇 |
2003年 | 265篇 |
2002年 | 296篇 |
2001年 | 223篇 |
2000年 | 239篇 |
1999年 | 230篇 |
1998年 | 109篇 |
1997年 | 85篇 |
1995年 | 68篇 |
1994年 | 61篇 |
1992年 | 97篇 |
1991年 | 80篇 |
1990年 | 98篇 |
1989年 | 123篇 |
1988年 | 116篇 |
1987年 | 95篇 |
1986年 | 108篇 |
1985年 | 121篇 |
1984年 | 70篇 |
1983年 | 69篇 |
1981年 | 54篇 |
1979年 | 85篇 |
1978年 | 60篇 |
1977年 | 63篇 |
1976年 | 53篇 |
1975年 | 58篇 |
1974年 | 50篇 |
1973年 | 75篇 |
1972年 | 61篇 |
1971年 | 77篇 |
1970年 | 59篇 |
1969年 | 59篇 |
1968年 | 51篇 |
排序方式: 共有7484条查询结果,搜索用时 78 毫秒
31.
Th. Büttner S. Schulz W. Kuhn A. Blumenschein H. Przuntek 《European journal of neurology》1994,1(2):153-157
Colour discrimination and visual contrast perception were investigated in 18 patients with Huntington's disease (HD) and in 18 age- and sex-matched healthy volunteers using the Farnsworth-Munsell 100 Hue test (FM) and stationary contrast targets. The mean total error score (MTES) and the partial scores for the “red-green” and the “blue-yellow” axes in the FM of the patients with HD were significantly elevated as compared to controls (MTES in HD: 113.0 ± 90.8; MTES in controls: 19.2 ± 8.8). The spatial contrast sensitivity in HD patients was normal. The colour perception dysfunction indicates that the visual system is affected in HD. The visual disorder may be related to an imbalance of certain neurotransmitters in the visual system of HD patients. Possible anatomical sites of the dysfunction responsible for colour discrimination abnormalities could be the retinal cone system and/or impaired parvocellular central visual pathways in HD. 相似文献
32.
33.
Conservative treatment options for patients with degenerative arthritis have changed over the past decade. Subjective recommendations in the past were converted to evidence-based guidelines, especially due to the work of the European League Against Rheumatism (EULAR). In the first place are changes in patient lifestyle, which unfortunately take place only in the minority of patients. The use of symptomatic slow-acting drugs for osteoarthritis (SYSADOAs) as well as hyaluronic acid has increased over the last years. Both have been shown to be effective in evidence-based studies. Glucosamine and chondroitin sulfate have proved to be effective if they are used at an adequate dosage and for an appropriate time interval (at least 3 months). A special advantage seems to be that the use of nonsteroidal anti-inflammatory drugs (NSAIDs) can be reduced. The positive effect of hyaluronic acids has recently been demonstrated by a Cochrane study; hyaluronic acids have a positive effect in early and midstage degenerative arthritis. The use of hyaluronic acids can also reduce the need for NSAIDs. 相似文献
34.
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. 总被引:4,自引:0,他引:4
Renzo Cescato Stefan Schulz Beatrice Waser Véronique Eltschinger Jean E Rivier Hans-Jürgen Wester Michael Culler Mihaela Ginj Qisheng Liu Agnes Schonbrunn Jean Claude Reubi 《Journal of nuclear medicine》2006,47(3):502-511
The uptake of radiolabeled somatostatin analogs by tumor cells through receptor-mediated internalization is a critical process for the in vivo targeting of tumoral somatostatin receptors. In the present study, the somatostatin receptor internalization induced by a variety of somatostatin analogs was measured with new immunocytochemical methods that allow characterization of trafficking of the somatostatin receptor subtype 2 (sst2), somatostatin receptor subtype 3 (sst3), and somatostatin receptor subtype 5 (sst5) in vitro at the protein level. METHODS: Human embryonic kidney 293 (HEK293) cells expressing the sst2, sst3, or the sst5 were used in a morphologic immunocytochemical internalization assay using specific sst2, sst3 and sst5 antibodies to qualitatively and quantitatively determine the capability of somatostatin agonists or antagonists to induce somatostatin receptor internalization. In addition, the internalization properties of a selection of these agonists have been compared and quantified in sst2-expressing CHO-K1 cells using an ELISA. RESULTS: Agonists with a high sst2-binding affinity were able to induce sst2 internalization in the HEK293 and CHO-K1 cell lines. New sst2 agonists, such as Y-DOTA-TATE, Y-DOTA-NOC, Lu-DOTA-BOC-ATE (where DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; TATE is [Tyr3, Thr8]-octreotide; NOC is [1-NaI3]-octreotide; and BOC-ATE is [BzThi3, Thr8]-octreotide), iodinated sugar-containing octreotide analogs, or BIM-23244 were considerably more potent in internalizing sst2 than was DTPA-octreotide (where DTPA is diethylenetriaminepentaacetic acid). Similarly, compounds with high sst3 affinity such as KE108 were able to induce sst3 internalization. In sst2- or sst3-expressing cell lines, agonist-induced receptor internalization was efficiently abolished by sst2- or sst3-selective antagonists, respectively. Antagonists alone had no effect on sst2 or sst3 internalization. We also showed that somatostatin-28 and somatostatin-14 can induce sst5 internalization. Unexpectedly, however, potent sst5 agonists such as KE108, BIM-23244, and L-817,818 were not able to induce sst5 internalization under the same conditions. CONCLUSION: Using sensitive and reproducible immunocytochemical methods, the ability of various somatostatin analogs to induce sst2, sst3, and sst5 internalization has been qualitatively and quantitatively determined. Whereas all agonists triggered sst2 and sst3 internalization, sst5 internalization was induced by natural somatostatin peptides but not by synthetic high-affinity sst5 agonists. Such assays will be of considerable help for the future characterization of ligands foreseen for nuclear medicine applications. 相似文献
35.
Astrid R. R. Heutelbeck Carsten Junghans Hermann Esselmann Ernst Hallier Thomas G. Schulz 《International archives of occupational and environmental health》2009,82(9):1123-1131
Introduction
Cattle are an important source of allergens in the working area of farmers. Asthma caused by cow allergens is a significant occupational problem. Yet in allergological testing, the results of in vivo and in vitro diagnostic tests are often inconsistent even in cases with clearly cattle-related symptoms. 相似文献36.
37.
AP de Moraes† ÉÂG de Arruda† MAV Vitoriano† MO de Moraes Filho‡ FÂF Bezerra‡ E de Magalhães Holanda§ MEA de Moraes‡ 《Journal of the European Academy of Dermatology and Venereology》2007,21(5):596-601
BACKGROUND: Seborrhoeic dermatitis (SD) is a common dermatosis in human immunodeficiency virus (HIV)-positive patients, many of whom do not respond satisfactorily to conventional topical treatments such as corticosteroids and antifungals. OBJECTIVE: A pilot study to investigate the efficacy and tolerability of pimecrolimus cream 1% in HIV-positive patients with facial SD. METHODS: In a single-centre study, 21 HIV-infected patients with mild to severe SD were treated twice daily with pimecrolimus cream 1% for 14 days. Thereafter, treatment was discontinued and patients followed up for 5 weeks. Skin involvement at baseline and on days 7, 14, 21, 35 and 49 was assessed using a four-point clinical score and digital photography. MAIN OUTCOME MEASURES: Efficacy and safety of pimecrolimus cream 1% treatment and incidence of relapse in the follow-up phase. Results Marked improvement was seen in clinical parameters at day 7, with >or= 90% patients clear of symptoms at day 14. Relapse was observed at day 35 but signs were milder than at baseline. All patients responded to therapy, despite their immunological status. Pimecrolimus did not alter CD4(+) and CD8(+) T-cell counts or viral load during the treatment period. CONCLUSION: Pimecrolimus cream represents a new, effective therapeutic option for facial SD in HIV patients. 相似文献
38.
Sybille Spicker Jörg B. Schulz Dirk Petersen Michael Fetter Thomas Klockgether Johannes Dichgans 《Journal of neurology》1995,242(8):517-521
Eye movements were studied in 13 patients with Friedreich's ataxia and correlated with MRI findings to investigate whether oculomotor abnormalities can be traced to cerebellar disturbances in this disease. One of the most prominent eye signs was fixation instability (square-wave jerks, SWJ.). Besides SWJ the patients showed various combinations of cerebellar, vestibular and brain-stem oculomotor signs. Our patients did not comprise a homogeneous group with regard to their oculomotor findings. There was no correlation between the severity of any of the so-called cerebellar oculomotor disturbances and the number of SWJ. We tried to correlate the extent of oculomotor disturbances with floccular atrophy and atrophy of the dorsal vermis on MRI in seven of the patients. None of the oculomotor features (including SWJ) correlated with flocculus or dorsal vermis size. Furthermore, floccular and vermal measurements on MRI were normal. Accordingly, we think it unlikely that the oculomotor disturbances, including SWJ, are attributable to cerebellar pathology per se. 相似文献
39.
40.
Comparative genomic hybridization (CGH) discloses chromosomal and subchromosomal copy number changes in Merkel cell carcinomas 总被引:1,自引:0,他引:1
M. Härle N. Arens I. Moll W. Back T. Schulz H. Scherthan 《Journal of cutaneous pathology》1996,23(5):391-397
We analyzed three Merkel cell carcinomas (MCC), applying comparative genomic hybridization (CGH) with DNA from paraffin-embedded and cultured tumor material as the probes. By this method, numerous changes in chromosome copy numbers were observed in each tumor investigated. Recurrent gains of chromosomes 1, 6, 18q and 20 were detected in two tumors. A third tumor showed complex chromosomal copy number changes, including gain of chromosome 8 and 9. These gains, as well as gain of chromosome 1 in the first two tumors, were confirmed by fluorescence in situ hybridization to paraffin tissue sections. Our results support the view that important genes for MCC development may be located on chromosomes 1, 6, 18q and 20. 相似文献